Secondary analysis of the ARCTIC trial in 227 patients with newly diagnosed RA starting methotrexate with 7-week prednisolone bridging: 84% had stopped prednisolone at 7 weeks, 89% at 3 months and 95% within 24 months; 22% used it continuously ≥3 months.
Secondary analysisn = 227
Brinkmann et al. Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritis